Sweden· SE-20140304000017
Suprefact Depot 9,45 mg Implantat
A medicinal product containing buserelin acetate, registered in Sweden by Medartuum AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Buserelin Acetate
- Manufacturer
- Medartuum AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- July 30, 2026
Packs & prices · 1
- se_varunummer20140304000017
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Buserelin acetate in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsSuprefact Depot 3 maanden, implantatiestift 9,45 mgMedcor Pharmaceuticals B.V.
- SpainSUPREFACT DEPOT 9,45 mg IMPLANTECheplapharm Arzneimittel Gmbh
- FinlandSuprefact DepotSanofi Oy
- United KingdomBuserelin 5.5mg/5.5ml solution for injection vialsNeon Healthcare Ltd
- ItalySUPREFACT*1 fiala SC 5,5 ml 1 mg/mlCHEPLAPHARM ARZNEIMITTEL GMBH
- GermanyMetrelefCheplapharm Arzneimittel Gmbh
- CanadaSUPREFACTCHEPLAPHARM ARZNEIMITTEL GMBH
- IcelandSuprecurSanofi-aventis Norge AS
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Suprecur, Suprefact
- Bulgaria · Супрефакт Депо 3 Месеца
- Germany · Profact Depot, Profact Pro Injectione
- Spain · Suprefact, Suprefact Depot
- United Kingdom (Northern Ireland) · Buserelin, Suprecur Injection
- Greece · Suprefact Depot 3 Μήνεσ
- Hungary · Suprefact
- Italy · Suprefact, Suprefact Depot
- Netherlands · Suprefact Depot
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf9fdbe5-96c9-4ae9-b0ad-754ea67610af GET /v1/drugs/bf9fdbe5-96c9-4ae9-b0ad-754ea67610af?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20140304000017",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20140304000017",
"product_doc_link": "https://docetp.mpa.se/LMF/Suprefact%20Depot%209%2C45%20mg%20implantat%20BG%20PL_09001bee807a866a.pdf"
}See everything about buserelin acetate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.